Theoretically, the increase of metastatic tumor sites and neoantigens caused by CDKN2A ALT provides an opportunity for the tumor-infiltrating white blood cells (TILs) to recognize and attack cancer cells in the tumor tissues. Here, CDKN2A is linked to neoplasm.